In the US, Tocilizumab (tocilizumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Cytokine Release Syndrome, Giant Cell Arteritis, Juvenile Idiopathic Arthritis, Rheumatoid Arthritis and Systemic Sclerosis.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
immunoglobulin G1, anti-(human interleukin 6 receptor) (human-mouse monoclonal MRA heavy chain), disulfide wit human-mouse monoclonal MRA kappa-chain, dimer (WHO)
- Tocilizumabum (Latin)
- Tocilizumab (German)
- Tocilizumab (French)
- Tocilizumab (Spanish)
- Tocilizumab (OS: USAN)
- Tocilizumab (Genetical Recombination) (OS: JAN)
- Atlizumab (IS)
- MRA (IS)
- R-1569 (IS)
Chugai, Georgia; Chugai Pharmaceutical, Japan; Dr. F. Hoffmann-Lja - Roche, Russian Federation; F. Hoffmann-La Roche, Macedonia; Genentech, United States; HOFFMANN, Israel; Hoffmann-La Roche, Bosnia & Herzegowina; Productos Roche, Chile; Roche, Armenia; Roche, Netherlands Antilles; Roche, Argentina; Roche, Australia; Roche, Aruba; Roche, Azerbaijan; Roche, Belarus; Roche, Canada; Roche, Ecuador; Roche, Hong Kong; Roche, Indonesia; Roche, Kyrgyzstan; Roche, Moldova; Roche, Myanmar; Roche, Malaysia; Roche, New Zealand; Roche, Peru; Roche, Philippines; Roche, Paraguay; Roche, Serbia; Roche, Thailand; Roche, Turkmenistan; Roche, Turkey; Roche, Uruguay; Roche, Vietnam; Roche, South Africa
Chugai Pharma, Kenya
Chugai, Germany; Hoffmann-La Roche Ltd, Latvia; Roche, Belgium; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Spain; Roche, Finland; Roche, France; Roche, Greece; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Ireland; Roche, Iceland; Roche, Italy; Roche, Lithuania; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, Poland; Roche, Portugal; Roche, Romania; Roche, Sweden; Roche, Slovenia; Roche Products, United Kingdom; Roche Registration, Austria
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.